Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents
摘要:
New dialkylimidazole based sterol 14 alpha-demethylase inhibitors were prepared and tested as potential anti-Trypanosoma cruzi agents. Previous studies had identified compound 2 as the most potent and selective inhibitor against parasite cultures. In addition, animal studies had demonstrated that compound 2 is highly efficacious in the acute model of the disease. However, compound 2 has a high molecular weight and high hydrophobicity, issues addressed here. Systematic modifications were carried out at four positions on the scaffold and several inhibitors were identified which are highly potent (EC50 <1 nM)against T. cruzi in culture. The halogenated derivatives 36j, 36k, and 36p, display excellent activity against T. cruzi amastigotes, with reduced molecular weight and lipophilicity, and exhibit suitable physicochemical properties for an oral drug candidate. (C) 2013 Elsevier Ltd. All rights reserved.
A Highly Para-Selective Copper(II)-Catalyzed Direct Arylation of Aniline and Phenol Derivatives
作者:Claire-Lise Ciana、Robert J. Phipps、Jochen R. Brandt、Falco-Magnus Meyer、Matthew J. Gaunt
DOI:10.1002/anie.201004703
日期:2011.1.10
In short order: A copper‐catalyzed Friedel–Crafts‐type strategy has been developed for the title reaction. An iterative CH arylation strategy has also been demonstrated for the functionalization of anilines by sequentially delivering different aromatic groups to the para, ortho, and meta positions (see scheme, Bn=benzyl, Piv=pivaloyl).
[EN] END CAPPED NUCLEIC ACID MOLECULES<br/>[FR] MOLÉCULES D'ACIDE NUCLÉIQUE À EXTRÉMITÉ COIFFÉE
申请人:NOVARTIS AG
公开号:WO2016098028A1
公开(公告)日:2016-06-23
The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.
The present invention generally concerns particular methods and compositions for antimicrobial therapy. In particular embodiments, the compositions target DXR. In specific embodiments, the compositions are electron-deficient heterocyclic rings.
2-Arylindoles are privileged structures widely present in biologically active molecules. New sustainable synthetic routes toward their synthesis are, therefore, in high demand. Herein, a mixed base-promoted benzylic C–H deprotonation of commercially available ortho-anisoles, addition of the resulting anion to benzonitriles, and SNAr to displace the methoxy group provide indoles. A diverse array of
2-Arylindoles 是广泛存在于生物活性分子中的特殊结构。因此,对其合成的新的可持续合成路线的需求量很大。在此,混合碱促进市售邻苯甲醚的苄基 C-H 去质子化,将所得阴离子添加到苯甲腈,以及用于置换甲氧基的S N Ar 提供吲哚。在不添加过渡金属催化剂的情况下,以良好的产率(>30 个实例,产率高达 99%)制备了多种多样的 2-芳基吲哚。
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
申请人:NOVARTIS AG
公开号:US10676499B2
公开(公告)日:2020-06-09
The disclosure relates to nucleic acids that contain modifications at the 5′-end, 3′-end or 5′-end and 3′-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.